Start with CleaCefaly is one option discussed in migraine care. Clea explains where it sits in the treatment landscape without recommending it for an individual person.
Frequency and symptoms can overlap: someone can have chronic migraine and vestibular symptoms, for example. Choose a label to explore usual roles, not to select a treatment for yourself.
General information, not personal medical advice. Some uses are off-label or supported by limited evidence. TGA approval, PBS eligibility and individual suitability differ. Do not start, stop or change treatment without your clinician or pharmacist.
Device-specific acute and/or preventive use, population and market approval must be checked. Not all devices or modes share the same evidence or Australian availability.
NICE headache guideline: migraine and cluster headacheDevice-specific acute and/or preventive use, population and market approval must be checked. Not all devices or modes share the same evidence or Australian availability.
NICE headache guideline: migraine and cluster headacheUse labels are an editorial guide to the cited sources, not a clinical recommendation or an independent clinical-review badge. Each profile retains its separate review status.
Non-invasive neuromodulation option for acute and/or preventive use depending device mode.
External forehead device.
Clinical studies support benefit for some people, though effect sizes vary.
Australian purchase/access should be checked with the supplier and clinician.
Neuromodulation devices use controlled electrical or magnetic stimulation to alter activity in nerve pathways involved in headache. The target, timing and evidence differ by device, so one device's evidence should not be generalised to another.
First establish whether the device is being used for acute treatment, prevention or both. Then track the outcome that matches that role, along with tolerability, ease of use and whether the device changes the need for other acute treatment.
Before and after a treatment change, record migraine-like days, total headache days, acute medicine days, severity and functional impact. If you notice side effects, record what happened and when rather than relying on memory at the next appointment.
Add to My TreatmentsUsually non-drug side effects; suitability and correct use still matter.
Clea does not recommend, start, stop or change medicines. Discuss individual treatment decisions with your GP, neurologist, pharmacist or other treating clinician.
People can report a migraine frequency and a symptom pattern separately, such as chronic plus vestibular. Labels are self-reported, not independently diagnosed or verified. Groups can overlap and cannot establish that one treatment works better than another.
Viewing: All migraine frequencies · All symptom patterns
Loading this group…
Small, self-selected groups are not clinical trials. Scores are perceived experiences and may reflect dose, treatment duration, other conditions and access as well as benefit. No personal identities are published here.
Log in to add your experienceAdd treatments you have tried to My Clea, then use your history when preparing for your next appointment.
Open My Clea